4 completed, 2 active not recruiting, 2 terminated, 1 withdrawn. 9 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 4, Active not recruiting 2, Terminated 2, Withdrawn 1 |
| Phase 1 | 2 | Active not recruiting 1, Withdrawn 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Postmenopausal Women: new trials by email Literature Review of Postmenopausal Women trials Research Report on Postmenopausal Women
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women Everolimus (Afinitor®), Football Fitness Concept - Postmenopausal Women | Phase 2 | Active not recruiting | Odense University Hospital | 136 | 2024-10-14 | 2026-04-07 |
| Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman Oxytocin, Placebo - Vaginal Atrophy, Oxytocin Gel | Phase 2 / Phase 3 | Terminated | Department of Medical Services Ministry of Public Health of Thailand | 6 | 2022-11-30 | 2023-08-31 |
| Tocotrienols for Skeletal Muscle Health placebo softgel, DeltaGold® Tocotrienol 70% - Dynapenia, Postmenopausal Women | Phase 1 / Phase 2 | Withdrawn | Texas Tech University Health Sciences Center | 2019-04-15 | 2022-02-18 | |
| Tocotrienols for Obesity of Postmenopausal Women placebo softgel, DeltaGold® Tocotrienol 70% - Obesity, Postmenopausal Women | Phase 1 / Phase 2 | Active not recruiting | Texas Tech University Health Sciences Center | 60 | 2019-03-15 | 2026-10-02 |
| Postmenopausal Women and Their Endothelium nitrate rich beetroot juice, nitrate depleted beetroot juice - Postmenopausal Women | Phase 2 | Completed | Penn State University | 37 | 2018-11-07 | 2023-02-27 |
| Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women Beetroot juice, Beetroot juice placebo - Postmenopausal Women | Phase 2 | Completed | Penn State University | 16 | 2014-09-12 | 2022-07-12 |
| Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Everolimus, Letrozole - Postmenopausal Women, Locally Advanced Metastatic Breast Cancer | Phase 2 | Completed | Novartis Pharmaceuticals | 72 | 2011-08-09 | 2021-03-26 |
| Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer fulvestrant (Faslodex), anastrozole (Arimidex), Bevacizumab (Avastin) - Non-small Cell Lung Cancer, Postmenopausal Women | Phase 2 | Terminated | University of Pittsburgh | 3 | 2010-09-01 | 2017-10-19 |
| Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate risedronate - Postmenopausal Women | Phase 2 | Completed | Warner Chilcott | 181 | 2006-07-01 | 2012-01-13 |
Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Motor Activity (1) · Obesity (1)
Neoplasms (2) · Neoplasms by Site (2) · Nutritional and Metabolic Diseases (2) · Behavior (1) · Body Weight (1) · Bone Diseases (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutrition Disorders (1) · Overnutrition (1)
Everolimus (2) · Olive Oil (2) · Tocotrienols (2) · Analgesics (1) · Anastrozole (1) · Anti-Bacterial Agents (1) · Antiemetics (1) · Bevacizumab (1) · Blood Transfusion (1) · Fulvestrant (1) · Letrozole (1) · Nutritional Support (1) · Oxytocin (1) · Pleurodesis (1) · Risedronic Acid (1)
Penn State University (2) · Texas Tech University Health Sciences Center (2) · Department of Medical Services Ministry of Public Health of Thailand (1) · Novartis Pharmaceuticals (1) · Odense University Hospital (1) · University of Pittsburgh (1) · Warner Chilcott (1)
United States (6) · Denmark (1) · Israel (1) · Thailand (1)
Chwan-Li Shen, PhD (2) · David N Proctor, PhD (2) · Ahmad Tarhini, MD (1) · Florence Figeac, PhD (1) · Lu A Sun, MD, PhD (1) · Moustapha Kassem, DMSc, PhD (1)